Abril and coworkers developed a small molecule inhibitor of SIRT5 called DK1-04e that inhibited the metastatic properties of breast cancer cells through desuccinylation of various metabolic enzymes, e.g., IDH, GLS, SHMT2, and PKM2, and significantly impaired tumor growth in experimental mice 89. Here, GLS is linked to breast cancer.